Sensory neuronopathy: finding the best disease scales for tracking progression
Official title: Clinical Evaluation of Sensory Neuronopathies: the Neuronoscore Study
Run by Centre Hospitalier Universitaire de Saint Etienne · NCT07651540 · Data updated 2026-11-12
This study tests which clinical scales best measure disease severity and progression in adults with sensory neuronopathy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Drugs / interventions | Chemotherapy |
| Locations | 19 sites (Angers and 18 other locations) |
| Status | Recruiting |
| Started | July 6, 2026 |
| Main results expected | June 25, 2028 |
| Study ends | June 25, 2028 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT07651540 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with probable sensory neuronopathy due to specified etiologies, able to read French, and affiliated with a social security system.
✕Probably not a fit
Patients with non-SN neuropathies or those unable to participate in serial assessments may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study monitors changes in clinical assessment scores over time in people with sensory neuronopathy to identify the most suitable tool for tracking progression. The goal is to determine a SN-specific or SN-appropriate scale that can reliably reflect disability and treatment response. Participants are adults diagnosed with probable SN and followed across several centers in France to compare available scales. The study emphasizes longitudinal scoring rather than a new drug intervention. No biomarker validation is described, focusing instead on scale performance and feasibility.
Why it matters
Potential benefit: If successful, patients may receive more accurate and meaningful measurements of their disease course, guiding care decisions.
How similar studies have gone: Previous SN-specific scales exist but have limited validation; this study explores their applicability in larger populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient affiliated with or beneficiary of a social security system * Patient having received appropriate study information * Adult patient ≥18 years old, male or female * Patient diagnosed with probable SN according to Camdessanché et al. diagnostic criteria * SN with one of the following etiologies: Paraneoplastic SN with anti-Hu or anti-CV2/CRMP5 antibodies SN associated with Sjögren's syndrome, systemic lupus erythematosus, or primary biliary cholangitis Platinum-salt-induced SN SN caused by CANVAS syndrome Exclusion Criteria: * Patient unable to understand or read French * Patient refusal to participate * Patient known to have another neuropathy phenotype and/or etiology that could significantly influence clinical scales and electrophysiological parameters, including: * Diabetes mellitus * Significant alcohol consumption * Severe chronic kidney disease (GFR \<30 ml/min) * Vitamin B12 and/or vitamin E deficiency * Vitamin B6 excess * Chemotherapy other than platinum salts * HIV infection
Where it's running
-
Chu de Saint-Etienne
Saint-Etienne, France Recruiting -
Chu D Angers
Angers, France Not yet recruiting -
Chu de Clermont Ferrand
Clermont-Ferrand, France Not yet recruiting -
Chu de Grenoble
Grenoble, France Not yet recruiting -
Chu de Lille
Lille, France Not yet recruiting -
Chu de Limoges
Limoges, France Not yet recruiting
Show 13 more locations
-
Hospices Civils de Lyon
Lyon, France Not yet recruiting -
Hopitaux Universitaire de Marseille
Marseille, France Not yet recruiting -
Chu de Nancy
Nancy, France Not yet recruiting -
Chu de Nantes
Nantes, France Not yet recruiting -
Chu de Nice
Nice, France Not yet recruiting -
Hopital, Bicetre
Paris, France Not yet recruiting -
CHU St Etienne
Saint-Etienne, France Not yet recruiting -
Chu de La Reunion
Saint-Pierre, France Not yet recruiting -
Hopitaux Universitaire de Strasbourg
Strasbourg, France Not yet recruiting -
Chu de Toulouse
Toulouse, France Not yet recruiting -
Hopitaux Universitaire de Geneve
Geneva, Switzerland Not yet recruiting -
Chuv Centre Hospitalier Vaudois
Lausanne, Switzerland Not yet recruiting -
Hopital de Sion
Sion, Switzerland Not yet recruiting
Study contacts
- Study coordinator: Jean philippe PHD CAMDESSANCHE
- Email: j.philippe.camdessanche@chu-st-etienne.fr
- Phone: +33 4 77 12 05 59
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single Port Robotic System for Pediatric Surgery
This study tests whether the Single Port robotic system can be safely used to perform certain pediatric abdominal surgeries (like pyeloplasty and reflux procedures) in children aged 1 to 17.
-
Multimodal approach to reduce urinary incontinence in young female athletes
A multimodal program combining pelvic health education and core stability training is tested to see if it reduces urinary incontinence in young nulliparous female athletes.
-
Remediation of memory impairments using motor encoding and dynamic imagery in Alzheimer’s disease
This trial tests whether combining real action, motor imagery, and dynamic video cues can help memory in people with early Alzheimer’s disease and compares it to a control group without Alzheimer’s.
-
Autologous Serum Eye Drops for Severe Dry Eye: Protein Factors and Response
This study tests whether the protein makeup of a patient’s own serum eye drops explains how well those drops work for severe dry eye.
-
Video therapy to help leg movement after stroke
A pilot study tests whether intensive video therapy added to usual rehabilitation can boost lower-limb recovery in people a month to a year after stroke.
-
Endurance Challenge: Can sedentary adults complete extreme endurance training
A group of previously inactive adults will try an 18-month intensive endurance program to see if a very ambitious training goal can help them start and stick with gradual, strenuous exercise.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.